Mycoplasma Pneumonia with Fulminant Evolution Into Diffuse Interstitial Fibrosis

Mycoplasma Pneumonia with Fulminant Evolution Into Diffuse Interstitial Fibrosis

Thorax: first published as 10.1136/thx.35.2.140 on 1 February 1980. Downloaded from Thorax, 1980, 35, 140-144 Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis J M KAUFMAN, C A CUVELIER, AND M VAN DER STRAETEN From the Departments of Medicine and Pathology, State University Hospital, Gent, Belgium ABSTRACT A fatal case of interstitial pneumonia caused by Mycoplasma pneumoniae with fulminant evolution into diffuse interstitial fibrosis is reported. Treatment with tetracycline and corticosteroids failed to arrest the progress of the disease. Fatal Mycoplasma pneumoniae infections have been reported previously and some degree of pulmonary fibrosis has been described in a few cases but as far as could be ascertained there are no other well-documented cases of diffuse interstitial fibrosis with proved Mycoplasma pneumoniae infection. Mycoplasma pneumoniae is a well-documented became more pronounced during the morning. and recognised cause of pneumonia, although in She also complained of vertigo and anorexia, and most cases infection remains subclinical or limited vomited once. The next morning she became to upper respiratory tract involvement.'-4 Clinical severely dyspnoeic and was admitted to a localcopyright. and radiographic features are inconstant and do hospital. Arterial blood gas analysis revealed a not allow for differentiation from pneumonias carbon dioxide tension (Pco2) of 35 mmHg and an caused by other micro-organisms.5 6 Mycoplasma oxygen tension (Po2) of 75 mmHg while breathing pneumoniae usually has a rather benign, self- 4 litres of oxygen per minute. The chest radio- limiting course. However, besides important extra- graph showed patchy lobular shadows involving pulmonary complications such as haemolytic both lower zones (fig 1). The patient was trans-http://thorax.bmj.com/ anaemia,7 8 myopericarditis,8-0 and neurological ferred to the intensive care unit of the University manifestations,3 4severe and even fatal respiratory Hospital, with tachypnoea (36 to 40/min), a tem- disease from Mycoplasma pneumoniae has been perature of 37 50C, and slightly diminished breath reported. The pulmonary complications include unilateral and bilateral massive pneumonia,31' 2 large unilateral and bilateral pleural effusions,3 11 13 lung abscess,3 12 Swyer-James syndrome,14 and extensive interstitial pneumonia with severe hy- on September 25, 2021 by guest. Protected poxaemia.15-'7 Although exceptional, persistence of respiratory symptoms after Mycoplasma pneu- moniae infection has been reported,' 8 and on a few occasions some degree of fibrosis has been demonstrated at necropsy'7-19 but this condition has not yet been well documented. Case report Sixteen days postpartum, a previously healthy 31-year-old woman complained of rhinitis and general malaise followed the next day by chills, fatigue, and non-productive cough. On the third night she woke up with mild dyspnoea which Fig 1 Chest radiograph (PA) on admission to shows lobular infiltration involving Address for reprint requests: Dr JM Kaufman, Department of hospital patchy Medicine, State University Hospital, Gent, Belgium. both lower zones. 140 Thorax: first published as 10.1136/thx.35.2.140 on 1 February 1980. Downloaded from Mycoplasma pneumonia with fulminant evolution into diffuse interstitial fibrosis 141 progressively. The patient went into gradually increasing alveolo-capillary block. Successive chest films showed increasing interstitial infiltrates all over the lungs with massive, patchy, confluent shadows in the lower parts and more reticular shadows in the upper parts with a picture suggest- ing advanced interstitial pneumonitis (fig 2). Sputa were purulent, but frequent cultures for aerobic and anaerobic bacteria, mycobacteria, and fungi were all negative. The patient died on the seventeenth day in hospital. At that time the blood gas values ranged around 90 mmHg Pco2 and 60 mmHg P02 despite ventilation. In one week, from the fourth to the tenth hospital day, the titre of complement fixing antibody for Myco- plasma pneumoniae rose from less than 1/4 to 1/128. No cold agglutinin titre could be demon- Fig 2 Chest radiograph (PA) on the fifteenth day in strated. Further studies on paired sera were nega- hospital shows diffuse mottling of both lungs. tive for Coxsackie 1-6, Varicella, influenza A-B, para-influenza 1-3, adenovirus, psittacosis, orni- thosis, and respiratory syncitial virus. sounds at the right base. Arterial blood gases on ambient air revealed a Pco2 of 38 mmHg and a NECROPSY P02 of 66 mmHg. The erythrocyte sedimentation The left lung weighed 800 g and the right lung rate was 100 mm/h, white cell counts 6800/mm3 1100 g. They both had a similar external aspect copyright. with 70% neutrophils. Treatment was started with with moderate reticular anthracosis and a purple- doxycycline intravenously, 200mg daily, and one grey to reddish appearance. The surface was dose of 25 mg prednisolone. nodular with fibrous pleura thickening. The lung The next day the patient seemed to improve; felt firm and the cut surface was reddish-grey chest radiograph was unchanged. During the next and white, intersected by round microcysts and two days, she had only mild dyspnoea but her white nodules. No purulent material could be http://thorax.bmj.com/ temperature rose to 390C and radiographs showed expressed. slightly increased infiltration of both bases. On microscopy similar changes were found in A technetium perfusion lung scan showed an all the lobes. The sections made of formalin-fixed area of diminished perfusion in the left paracar- and paraffin-embedded lung tissue were stained diac area, and on the fourth day in hospital, in with haematoxylin-eosin, PAS, Masson's tri- addition to doxycycline, heparin was started in a chrome, and reticulin. They showed a diffuse inter- dose of 37500 units/day by continuous infusion. stitial fibrosis (fig 3). The bronchioles were grouped On the fifth day the patient's condition deterior- in nodules, dilated and covered with a metaplastic on September 25, 2021 by guest. Protected ated quickly, with extreme dyspnoea and severe stratified, flattened or squamous epithelium. Some respiratory distress. Arterial blood gas analysis showed cystic dilatation and contained mucus, breathing 10 litres/min with an oxygen mask, occasional giant cells, histocytes, polymorph leu- showed pH 7-58, Pco2 29-5 mmHg, and P02 cocytes, and monocytes. 34.5 mmHg. The patient became apnoeic and was Severe fibrosis was seen in the thickened inter- immediately intubated and ventilated. Doxycy- alveolar septa and around the bronchioles. The cline and heparin were continued, and in addition fibrous tissue consisted of young fusiform fibro- the patient received high doses of betamethasone. blasts which formed collagen. Inside the fibrous For two days there was a progressive improvement tissue it was possible to distinguish small haemor- with satisfactory blood gas values on PEEP 10 cm rhages, oedema fluid, and the alveolar capillaries H20 and 50% inspired oxygen initially, reduc- which were increased in size and number and ing to 25% later on. The chest radiograph showed surrounded by a cellular infiltrate. Within the progressive changes, with some early reticular fibrotic interstitial tissue the presence of mono- infiltrates in the upper zones. The white cell was cytes and histocytes was observed. The alveolar between 15 000 and 20 000/mm3. On the tenth walls were covered by cuboidal cells with abun- day in hospital the situation deteriorated again dant, foamy cytoplasm with round vesicular Thorax: first published as 10.1136/thx.35.2.140 on 1 February 1980. Downloaded from 142 J M Kaufman, C A Cuvelier, and M Van der Straeten ¶ '¶4, 4 N copyright. Fig 3 Severe interstitial fibrosis with fibroblast proliferation and monocellular infiltrate. Masson's trichrome stain, original magnification X 140. http://thorax.bmj.com/ nuclei. Some had desquamated into the lumen. date into the alveolar walls. Afterwards, fibro- The alveoli were filled with a homogenous exu- blast proliferation starts between the sixth and date, haemosiderin laden macrophages, polymorph ninth day and gives rise to more organised and leucocytes, erythrocytes, and giant cells (fig 4). mature fibrous tissue. The alveolar lining epi- Fibrin was seen only occasionally. The pleura thelium is changed into type 2 pneumocytes and was thickened by bundles of collagen fibres. the bronchiolar lining epithelium grows into the respiratory bronchiole which causes squamous on September 25, 2021 by guest. Protected Discussion metaplasia. Numerous different agents are known to cause Mycoplasma pneumoniae has been mentioned as diffuse interstitial fibrosis. It may follow radiation a possible cause of interstitial fibrosis20-22 but only therapy, oxygen toxicity, anti-neoplastic drugs, in a few cases has some degree of fibrosis been re- paraquat poisoning, inhalation of organic or ported.17-19 There are no well-documented cases mineral dust and toxic fumes. It is also seen as in which evolution of a Mycoplasma pneumoniae a terminal phase of sarcoidosis, collagen diseases, pneumonia into diffuse interstitial fibrosis has been miscellaneous occupational diseases and other described. The mechanisms leading to the patho- interstitial pneumonias. Infectious diseases have logical changes in diffuse interstitial fibrosis are also been implicated including bacterial, viral, well known but not specific. The alterations can fungal and parasitic infections. In our case, there be the result either of

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    5 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us